These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6125282)

  • 1. Review of therapeutic modalities acting directly via central pathways.
    Oparil S
    Clin Exp Hypertens A; 1982; 4(4-5):579-93. PubMed ID: 6125282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypotensive activity and side effects of methyldopa, clonidine, and guanfacine.
    van Zwieten PA; Thoolen MJ; Timmermans PB
    Hypertension; 1984; 6(5 Pt 2):II28-33. PubMed ID: 6094346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents.
    Langer SZ; Cavero I; Massingham R
    Hypertension; 1980; 2(4):372-82. PubMed ID: 6105128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of centrally acting hypotensive drugs.
    van Zwieten PA
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):13S-20S. PubMed ID: 6104975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In summary: satellite symposium on central alpha-adrenergic blood pressure regulating mechanisms.
    Abrams WB
    Hypertension; 1984; 6(5 Pt 2):II87-93. PubMed ID: 6150004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New centrally acting antihypertensive drugs related to methyldopa and clonidine.
    Sweet CS
    Hypertension; 1984; 6(5 Pt 2):II51-6. PubMed ID: 6094350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular regulation by central adrenergic mechanisms and its alteration by hypotensive drugs.
    Haeusler G
    Circ Res; 1975 Jun; 36(6 Suppl 1):223-32. PubMed ID: 1093754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central alpha-adrenergic systems as targets for hypotensive drugs.
    Kobinger
    Rev Physiol Biochem Pharmacol; 1978; 81():39-100. PubMed ID: 25484
    [No Abstract]   [Full Text] [Related]  

  • 9. From alpha and beta to I1: an overview of sympathetic receptors involved in blood pressure control targets for drug treatment.
    van Zwieten PA
    J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S5-10. PubMed ID: 8872294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive drugs that alter adrenergic function.
    Weinshilboum RM
    Mayo Clin Proc; 1980 Jun; 55(6):390-402. PubMed ID: 6103981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology and characterization of central alpha-adrenoceptors involved in the effect of centrally acting antihypertensive drugs.
    van Zwieten PA; Timmermans PB
    Chest; 1983 Feb; 83(2 Suppl):340-3. PubMed ID: 6295709
    [No Abstract]   [Full Text] [Related]  

  • 12. [Centrally acting sympathetic inhibitors for therapy of patients with hypertension].
    Kawasaki H
    Nihon Rinsho; 1997 Aug; 55(8):2081-5. PubMed ID: 9284427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of sympathetic preganglionic neurons by catecholamines and clonidine: mediation by an alpha-adrenergic receptor.
    Guyenet PG; Cabot JB
    J Neurosci; 1981 Aug; 1(8):908-17. PubMed ID: 6286903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of imidazoline-preferring receptors in regulation of sympathetic tone.
    Sannajust F; Head GA
    Am J Cardiol; 1994 Dec; 74(13):7A-19A. PubMed ID: 7998588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of centrally acting alpha-adrenergic agonists on sympathetic nervous system function in humans.
    Brown MJ; Harland D; Murphy MB; Struthers AD
    Hypertension; 1984; 6(5 Pt 2):II57-62. PubMed ID: 6150000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-2 adrenergic transmission and human baroreflex regulation.
    Tank J; Diedrich A; Szczech E; Luft FC; Jordan J
    Hypertension; 2004 May; 43(5):1035-41. PubMed ID: 15037555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of alpha-sympathomimetic agents in the central nervous system. Study of the central effects of adrenergic drugs by injection into the vertebral artery].
    Van Zwieten PA
    Therapie; 1972; 27(4):565-75. PubMed ID: 4404301
    [No Abstract]   [Full Text] [Related]  

  • 18. New central mediators as targets of centrally acting antihypertensive drugs.
    van Zwieten PA
    Clin Exp Hypertens; 1996; 18(3-4):291-303. PubMed ID: 8743022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-adrenergic mechanisms in the pathophysiology of left ventricular heart failure--an analysis of their role in systolic and diastolic dysfunction.
    Giles TD; Sander GE; Thomas MG; Quiroz AC
    J Mol Cell Cardiol; 1986 Nov; 18 Suppl 5():33-43. PubMed ID: 2879938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why imidazoline receptor modulator in the treatment of hypertension?
    Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
    Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.